
Virtual drug design platform set to accelerate drug discovery
The Cambridge Crystallographic Data Centre (CCDC) has entered a strategic partnership with Dassault Systèmes to advance bioscience innovation with a cloud-based virtual screening solution. The collaboration The collaboration integrates GOLD — CCDC’s protein-ligand docking software for drug discovery — with Dassault Systèmes’ BIOVIA therapeutics design… Read More















